Symposium zeroes in on new discoveries in breast cancer.
作者信息
Printz Carrie
出版信息
Cancer. 2011 Mar 15;117(6):1107-8. doi: 10.1002/cncr.26023.
PMID:21381004
Abstract
摘要
相似文献
1
Symposium zeroes in on new discoveries in breast cancer.研讨会聚焦乳腺癌的新发现。
Cancer. 2011 Mar 15;117(6):1107-8. doi: 10.1002/cncr.26023.
2
[Health care expenditures linked to the use of targeted therapies and diagnostic tests for cancer patients].[与癌症患者使用靶向治疗和诊断检测相关的医疗保健支出]
Med Sci (Paris). 2012 Mar;28 Spec No 1:19-23. doi: 10.1051/medsci/2012281s106. Epub 2012 Apr 9.
3
[The RARE 2017 meeting and the French Foundation of Rare Diseases].[2017年罕见病会议与法国罕见病基金会]
Med Sci (Paris). 2018 May;34 Hors série n°1:8. doi: 10.1051/medsci/201834s105. Epub 2018 Jun 18.
4
[Needs for more R&D in the field of rare diseases].罕见病领域对更多研发的需求
Med Sci (Paris). 2018 May;34 Hors série n°1:48-49. doi: 10.1051/medsci/201834s125. Epub 2018 Jun 18.
5
Can open-source drug R&D repower pharmaceutical innovation?开源药物研发能否重振药物创新？
Clin Pharmacol Ther. 2010 May;87(5):534-6. doi: 10.1038/clpt.2010.26.
6
The future is much closer collaboration between the pharmaceutical industry and academic medical centers.未来制药行业与学术医疗中心之间将有更紧密的合作。
Clin Pharmacol Ther. 2010 May;87(5):525-7. doi: 10.1038/clpt.2010.29.
7
The need for precompetitive integrative bionetwork disease model building.需要建立竞争前整合生物网络疾病模型。
Clin Pharmacol Ther. 2010 May;87(5):536-9. doi: 10.1038/clpt.2010.40.
8
Advances in translational research in breast cancer; a bridge to future therapies.乳腺癌转化研究的进展；通向未来疗法的桥梁。
Eur J Cancer. 2008 Dec;44(18):2705-6. doi: 10.1016/j.ejca.2008.10.007. Epub 2008 Nov 21.
9
Tuberculosis vaccines: a strategic blueprint for the next decade.结核病疫苗：未来十年的战略蓝图。
Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S6-13. doi: 10.1016/S1472-9792(12)70005-7.
10
Could pharma open its drug freezers?制药公司能打开其药品冷冻柜吗？
Nat Rev Drug Discov. 2011 Jun;10(6):399-400. doi: 10.1038/nrd3473.
Zotero 插件